NCT03331250 2025-12-23Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)Massachusetts General HospitalPhase 2 Active not recruiting13 enrolled 9 charts
NCT03361436 2025-09-16Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by SurgeryOHSU Knight Cancer InstitutePhase 1 Active not recruiting15 enrolled
NCT06263231 2025-07-29INVINCIBLE-3Intensity Therapeutics, Inc.Phase 3 Active not recruiting333 enrolled